EUVIMEDEUVIMED entdecken
Crossref

74. FIRE: Lightening the Mind: Low-Dose Naltrexone to Treat Autoimmune-Related Mood Disorders

Lay Kodama, Michaela Rand, Lama Muhammad

Journal of the Academy of Consultation-Liaison Psychiatry · 2026-11 · 67 · S106

DOI: 10.1016/j.jaclp.2026.10.173 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the Academy of Consultation-Liaison Psychiatry, 2026-11. Verfasst von Lay Kodama und 2 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Kodama, L., Rand, M., & Muhammad, L. (2026). 74. FIRE: Lightening the Mind: Low-Dose Naltrexone to Treat Autoimmune-Related Mood Disorders. Journal of the Academy of Consultation-Liaison Psychiatry, 67, S106. https://doi.org/10.1016/j.jaclp.2026.10.173

Vancouver

Kodama L, Rand M, Muhammad L. 74. FIRE: Lightening the Mind: Low-Dose Naltrexone to Treat Autoimmune-Related Mood Disorders. Journal of the Academy of Consultation-Liaison Psychiatry. 2026;67:S106. doi:10.1016/j.jaclp.2026.10.173

BibTeX
@article{Kodama2026,
  author = {Kodama, Lay and Rand, Michaela and Muhammad, Lama},
  title = {74. FIRE: Lightening the Mind: Low-Dose Naltrexone to Treat Autoimmune-Related Mood Disorders},
  journal = {Journal of the Academy of Consultation-Liaison Psychiatry},
  year = {2026},
  volume = {67},
  pages = {S106},
  doi = {10.1016/j.jaclp.2026.10.173}
}
Kostenlos starten →